Literature DB >> 23815678

Isolation and in vitro culture of rare cancer stem cells from patient-derived xenografts of pancreatic ductal adenocarcinoma.

Philip C Gach1, Peter J Attayek, Gabriela Herrera, Jen Jen Yeh, Nancy L Allbritton.   

Abstract

Described is the construction of a large array of releasable microstructures (micropallets) along with screening and isolation protocols for sorting rare, approximately 1 in 10,000, cancer stem cells (CSCs) from a heterogeneous cell popn>ulation. A 10.1 × 7.1 cm array of micropn>allets (50 × 50 × 75 μm structures and 25 μm micropn>allet gapn>) was fabricated on a large glass substrate, providing an array of apn>proximately 1.3 million releasable microstructures. Image analysis algorithms were developn>ed to permit array screening for identification of fluorescently labeled cells in less than 15 min using an epifluorescent wide-field microscopn>e with a compn>uter controlled translational stage. Device opn>eration was tested by culturing n>an class="CellLine">HeLa cells transfected with green fluorescent protein (GFP) admixed with wild-type HeLa cells at ratios of 1:10(4) to 1:10(6) on the array followed by screening to identify flourescent cells. Micropallets containing cells of interest were then selectively released by a focused laser pulse and collected on a numbered poly(dimethylsiloxane) (PDMS) substrate with high viability. A direct comparison of this technology with fluorescence-activated cell sorting (FACS) demonstrated that micropallet arrays offered enhanced post sorting purity (100%), yield (100%), and viability (94-100%) for rare cell isolation. As a demonstration of the technology's value, pancreatic tumor cells from Panc-1 cell lines and patient-derived xenografts were screened for the presence of CD24, CD44, and CD326: surface markers of pancreatic CSCs. Following cell isolation and culture, 63 ± 23% of the isolated Panc-1 cells and 35% of sorted human xenograft cells formed tumor spheroids retaining high expression levels of CD24, CD44, and CD326. The ability to isolate rare cells from relatively small sample sizes will facilitate our understanding of cell biology and the development of new therapeutic strategies.

Entities:  

Mesh:

Year:  2013        PMID: 23815678      PMCID: PMC3754897          DOI: 10.1021/ac401165s

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  29 in total

Review 1.  High-speed cell sorting: fundamentals and recent advances.

Authors:  Sherrif F Ibrahim; Ger van den Engh
Journal:  Curr Opin Biotechnol       Date:  2003-02       Impact factor: 9.740

2.  Evaluation of membrane physiology following fluorescence activated or magnetic cell separation.

Authors:  J Seidl; R Knuechel; L A Kunz-Schughart
Journal:  Cytometry       Date:  1999-06-01

Review 3.  Metastatic inefficiency.

Authors:  L Weiss
Journal:  Adv Cancer Res       Date:  1990       Impact factor: 6.242

4.  Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells.

Authors:  G Vona; A Sabile; M Louha; V Sitruk; S Romana; K Schütze; F Capron; D Franco; M Pazzagli; M Vekemans; B Lacour; C Bréchot; P Paterlini-Bréchot
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

5.  Prospective identification of tumorigenic breast cancer cells.

Authors:  Muhammad Al-Hajj; Max S Wicha; Adalberto Benito-Hernandez; Sean J Morrison; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

6.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.

Authors:  D Bonnet; J E Dick
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

7.  Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases.

Authors:  K J Luzzi; I C MacDonald; E E Schmidt; N Kerkvliet; V L Morris; A F Chambers; A C Groom
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

8.  A rare-cell detector for cancer.

Authors:  Robert T Krivacic; Andras Ladanyi; Douglas N Curry; H B Hsieh; Peter Kuhn; Danielle E Bergsrud; Jane F Kepros; Todd Barbera; Michael Y Ho; Lan Bo Chen; Richard A Lerner; Richard H Bruce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

9.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer.

Authors:  Massimo Cristofanilli; G Thomas Budd; Matthew J Ellis; Alison Stopeck; Jeri Matera; M Craig Miller; James M Reuben; Gerald V Doyle; W Jeffrey Allard; Leon W M M Terstappen; Daniel F Hayes
Journal:  N Engl J Med       Date:  2004-08-19       Impact factor: 91.245

Review 10.  Dissemination and growth of cancer cells in metastatic sites.

Authors:  Ann F Chambers; Alan C Groom; Ian C MacDonald
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

View more
  6 in total

1.  NOTCH1 and SOX10 are Essential for Proliferation and Radiation Resistance of Cancer Stem-Like Cells in Adenoid Cystic Carcinoma.

Authors:  Alex Panaccione; Michael T Chang; Beatrice E Carbone; Yan Guo; Christopher A Moskaluk; Renu K Virk; Luis Chiriboga; Manju L Prasad; Benjamin Judson; Saral Mehra; Wendell G Yarbrough; Sergey V Ivanov
Journal:  Clin Cancer Res       Date:  2016-04-15       Impact factor: 12.531

Review 2.  A technology of a different sort: microraft arrays.

Authors:  Belén Cortés-Llanos; Yuli Wang; Christopher E Sims; Nancy L Allbritton
Journal:  Lab Chip       Date:  2021-08-04       Impact factor: 7.517

3.  Hedgehog Signaling Regulates Epithelial-Mesenchymal Transition in Pancreatic Cancer Stem-Like Cells.

Authors:  Feng Wang; Ling Ma; Zhengkui Zhang; Xiaoran Liu; Hongqiao Gao; Yan Zhuang; Pei Yang; Marko Kornmann; Xiaodong Tian; Yinmo Yang
Journal:  J Cancer       Date:  2016-01-20       Impact factor: 4.207

Review 4.  Using Pharmacogenomic Databases for Discovering Patient-Target Genes and Small Molecule Candidates to Cancer Therapy.

Authors:  José E Belizário; Beatriz A Sangiuliano; Marcela Perez-Sosa; Jennifer M Neyra; Dayson F Moreira
Journal:  Front Pharmacol       Date:  2016-09-29       Impact factor: 5.810

5.  MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell.

Authors:  Yuhua Lu; Jingjing Lu; Xiaohong Li; Hui Zhu; Xiangjun Fan; Shajun Zhu; Yao Wang; Qingsong Guo; Lei Wang; Yan Huang; Mingyan Zhu; Zhiwei Wang
Journal:  BMC Cancer       Date:  2014-02-12       Impact factor: 4.430

6.  Highly efficient cellular cloning using Ferro-core Micropallet Arrays.

Authors:  Trisha M Westerhof; Wesley A Cox-Muranami; Guann-Pyng Li; Mark Bachman; Hung Fan; Edward L Nelson
Journal:  Sci Rep       Date:  2017-10-12       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.